Incorporation of antimicrobial compounds in mesoporous silica film monolith - PubMed (original) (raw)
Incorporation of antimicrobial compounds in mesoporous silica film monolith
Isabel Izquierdo-Barba et al. Biomaterials. 2009 Oct.
Abstract
Incorporation of the antimicrobial peptide LL-37 (LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES), as well as low molecular weight antimicrobial chlorhexidine, into mesoporous silica was obtained using an EISA one-pot synthesis method. FTIR confirmed efficient encapsulation of both LL-37 and chlorhexidine into mesoporous silica, while XRD and TEM showed that antimicrobial agent incorporation can be achieved without greatly affecting the structure of the mesoporous silica. The modified mesoporous silica released LL-37 and chlorhexidine slowly, reaching maximum release after about 200 h. The release rate could also be controlled through incorporation of SH groups in the pore walls, adding to pore hydrophobicity and reducing the release rate by about 50% compared to the unmodified mesoporous silica. Mesoporous silica containing either LL-37 or chlorhexidine displayed potent bactericidal properties against both Gram-positive Staphylococcus aureus and Gram-negative Escherichia coli. While chlorhexidine-loaded mesoporous silica displayed an accompanying high toxicity, as judged from hemolysis, LDH release, and MTT assay, the corresponding material containing LL-37 showed very low toxicity by all these assays, comparable to that observed for mesoporous silica in the absence of antibacterial drug, as well as to the negative controls in the respective assays. Mesoporous silica containing LL-37 therefore holds potential as an implantable material or a surface coating for such materials, as it combines potent bactericidal action with low toxicity, important features for controlling implant-related infections, e.g., for multi-resistant pathogens or for cases where access to the infection site of systemically administered antibiotics is limited due to collagen capsule formation or other factors.
Similar articles
- Membrane interactions of mesoporous silica nanoparticles as carriers of antimicrobial peptides.
Braun K, Pochert A, Lindén M, Davoudi M, Schmidtchen A, Nordström R, Malmsten M. Braun K, et al. J Colloid Interface Sci. 2016 Aug 1;475:161-170. doi: 10.1016/j.jcis.2016.05.002. Epub 2016 May 5. J Colloid Interface Sci. 2016. PMID: 27174622 - Synthesis, amino-functionalization of mesoporous silica and its adsorption of Cr(VI).
Li J, Miao X, Hao Y, Zhao J, Sun X, Wang L. Li J, et al. J Colloid Interface Sci. 2008 Feb 15;318(2):309-14. doi: 10.1016/j.jcis.2007.09.093. Epub 2007 Oct 9. J Colloid Interface Sci. 2008. PMID: 18036539 - Synthesis of hierarchically nanoporous silica films for controlled drug loading and release.
Xu M, Feng D, Dai R, Wu H, Zhao D, Zheng G. Xu M, et al. Nanoscale. 2011 Aug;3(8):3329-33. doi: 10.1039/c1nr10477b. Epub 2011 Jun 30. Nanoscale. 2011. PMID: 21717013 - Ordered mesoporous silica (OMS) as an adsorbent and membrane for separation of carbon dioxide (CO2).
Chew TL, Ahmad AL, Bhatia S. Chew TL, et al. Adv Colloid Interface Sci. 2010 Jan 15;153(1-2):43-57. doi: 10.1016/j.cis.2009.12.001. Epub 2010 Jan 4. Adv Colloid Interface Sci. 2010. PMID: 20060956 Review. - Capped mesoporous silica nanoparticles as stimuli-responsive controlled release systems for intracellular drug/gene delivery.
Zhao Y, Vivero-Escoto JL, Slowing II, Trewyn BG, Lin VS. Zhao Y, et al. Expert Opin Drug Deliv. 2010 Sep;7(9):1013-29. doi: 10.1517/17425247.2010.498816. Expert Opin Drug Deliv. 2010. PMID: 20716017 Review.
Cited by
- Editorial: Antimicrobial peptides and their druggability, bio-safety, stability, and resistance.
Ma X, Aminov R, Franco OL, de la Fuente-Nunez C, Wang G, Wang J. Ma X, et al. Front Microbiol. 2024 May 23;15:1425952. doi: 10.3389/fmicb.2024.1425952. eCollection 2024. Front Microbiol. 2024. PMID: 38846567 Free PMC article. No abstract available. - Enhancing the inhibition of dental erosion and abrasion with quercetin-encapsulated hollow mesoporous silica nanocomposites.
Chen JM, Cheng YL, Yang MH, Su C, Yu H. Chen JM, et al. Front Bioeng Biotechnol. 2024 Feb 8;12:1343329. doi: 10.3389/fbioe.2024.1343329. eCollection 2024. Front Bioeng Biotechnol. 2024. PMID: 38405377 Free PMC article. - _N_-Phenyl acrylamide-incorporated porous silica-bound graphene oxide sheets with excellent removal capacity for Cr(iii) and Cr(vi) from wastewater.
Khan M, Ali F, Ramzan S, AlOthman ZA. Khan M, et al. RSC Adv. 2023 May 30;13(24):16047-16066. doi: 10.1039/d3ra02568c. eCollection 2023 May 30. RSC Adv. 2023. PMID: 37260720 Free PMC article. - Inorganic hollow mesoporous spheres-based delivery for antimicrobial agents.
Qiao Y, Han Y, Guan R, Liu S, Bi X, Liu S, Cui W, Zhang T, He T. Qiao Y, et al. Front Mater Sci. 2023;17(1):230631. doi: 10.1007/s11706-023-0631-2. Epub 2023 Mar 8. Front Mater Sci. 2023. PMID: 36911597 Free PMC article. Review. - Development of Autopolymerizing Resin Material with Antimicrobial Properties Using Montmorillonite and Nanoporous Silica.
Otsubo S, Nakanishi K, Fukukawa K, Endo R, Yoshida S, Matsumoto A, Yoshihara K, Akasaka T, Hasebe A, Yoshida Y, Sato Y. Otsubo S, et al. Pharmaceutics. 2023 Feb 6;15(2):544. doi: 10.3390/pharmaceutics15020544. Pharmaceutics. 2023. PMID: 36839866 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical